ALK fusion proteins have been found be critical oncogenic drivers in some cancers, such as non-small cell lung cancer (NSCLC) [59,60], ALCL [1,2], and inflammatory myofibroblastic tumor (IMT) [61,62]. This evidence concerns the gene ALK and cancer.